Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
JD Health International, Inc. ( (HK:6618) ) has provided an update.
JD Health International Inc. has announced an extraordinary general meeting to be held on December 8, 2025, to approve several agreements with JD.com. These agreements include the provision of technology and traffic support, healthcare products and services, marketing services, and integrated supply chain solutions, with transactions and annual caps set for the next three years. This move is expected to strengthen JD Health’s operational capabilities and market positioning, potentially impacting stakeholders by enhancing service offerings and efficiency.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$66.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International Inc. operates in the healthcare industry, providing a range of services including technology and traffic support, healthcare products and services, marketing services, and integrated supply chain solutions and logistics services. The company is a subsidiary of JD.com and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 8,993,890
Technical Sentiment Signal: Buy
Current Market Cap: HK$207.1B
See more data about 6618 stock on TipRanks’ Stock Analysis page.